302 related articles for article (PubMed ID: 33006233)
1. COVID-19 is an emergent disease of aging.
Santesmasses D; Castro JP; Zenin AA; Shindyapina AV; Gerashchenko MV; Zhang B; Kerepesi C; Yim SH; Fedichev PO; Gladyshev VN
Aging Cell; 2020 Oct; 19(10):e13230. PubMed ID: 33006233
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).
Bourgonje AR; Abdulle AE; Timens W; Hillebrands JL; Navis GJ; Gordijn SJ; Bolling MC; Dijkstra G; Voors AA; Osterhaus AD; van der Voort PH; Mulder DJ; van Goor H
J Pathol; 2020 Jul; 251(3):228-248. PubMed ID: 32418199
[TBL] [Abstract][Full Text] [Related]
3. Inflamm-aging: Why older men are the most susceptible to SARS-CoV-2 complicated outcomes.
Bonafè M; Prattichizzo F; Giuliani A; Storci G; Sabbatinelli J; Olivieri F
Cytokine Growth Factor Rev; 2020 Jun; 53():33-37. PubMed ID: 32389499
[TBL] [Abstract][Full Text] [Related]
4. Do sex-specific immunobiological factors and differences in angiotensin converting enzyme 2 (ACE2) expression explain increased severity and mortality of COVID-19 in males?
Vikse J; Lippi G; Henry BM
Diagnosis (Berl); 2020 Nov; 7(4):385-386. PubMed ID: 32549125
[TBL] [Abstract][Full Text] [Related]
5. Could Sex/Gender Differences in ACE2 Expression in the Lungs Contribute to the Large Gender Disparity in the Morbidity and Mortality of Patients Infected With the SARS-CoV-2 Virus?
Majdic G
Front Cell Infect Microbiol; 2020; 10():327. PubMed ID: 32582576
[TBL] [Abstract][Full Text] [Related]
6. Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19.
Cheng H; Wang Y; Wang GQ
J Med Virol; 2020 Jul; 92(7):726-730. PubMed ID: 32221983
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 receptor ACE2-dependent implications on the cardiovascular system: From basic science to clinical implications.
Groß S; Jahn C; Cushman S; Bär C; Thum T
J Mol Cell Cardiol; 2020 Jul; 144():47-53. PubMed ID: 32360703
[TBL] [Abstract][Full Text] [Related]
8. Molecular Basis of Pathogenesis of Coronaviruses: A Comparative Genomics Approach to Planetary Health to Prevent Zoonotic Outbreaks in the 21st Century.
Asrani P; Hasan GM; Sohal SS; Hassan MI
OMICS; 2020 Nov; 24(11):634-644. PubMed ID: 32940573
[TBL] [Abstract][Full Text] [Related]
9. The Expression and Polymorphism of Entry Machinery for COVID-19 in Human: Juxtaposing Population Groups, Gender, and Different Tissues.
Darbani B
Int J Environ Res Public Health; 2020 May; 17(10):. PubMed ID: 32423095
[TBL] [Abstract][Full Text] [Related]
10. Can estrogens protect against COVID-19? The COVID-19 puzzling and gender medicine.
Bonaccorsi G; Gambacciani M; Gemmati D
Minerva Ginecol; 2020 Jun; 72(3):178-179. PubMed ID: 33000616
[No Abstract] [Full Text] [Related]
11. Sex-Specific SARS-CoV-2 Mortality: Among Hormone-Modulated ACE2 Expression, Risk of Venous Thromboembolism and Hypovitaminosis D.
La Vignera S; Cannarella R; Condorelli RA; Torre F; Aversa A; Calogero AE
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331343
[TBL] [Abstract][Full Text] [Related]
12. Searching therapeutic strategy of new coronavirus pneumonia from angiotensin-converting enzyme 2: the target of COVID-19 and SARS-CoV.
Li SR; Tang ZJ; Li ZH; Liu X
Eur J Clin Microbiol Infect Dis; 2020 Jun; 39(6):1021-1026. PubMed ID: 32285293
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy.
Datta PK; Liu F; Fischer T; Rappaport J; Qin X
Theranostics; 2020; 10(16):7448-7464. PubMed ID: 32642005
[TBL] [Abstract][Full Text] [Related]
14. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 and chronological aging: senolytics and other anti-aging drugs for the treatment or prevention of corona virus infection?
Sargiacomo C; Sotgia F; Lisanti MP
Aging (Albany NY); 2020 Mar; 12(8):6511-6517. PubMed ID: 32229706
[TBL] [Abstract][Full Text] [Related]
16. Coronavirus Disease 2019 (COVID-19): Do Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect?
Sommerstein R; Kochen MM; Messerli FH; Gräni C
J Am Heart Assoc; 2020 Apr; 9(7):e016509. PubMed ID: 32233753
[No Abstract] [Full Text] [Related]
17. Coronavirus disease 2019 (COVID-19) and the renin-angiotensin system: A closer look at angiotensin-converting enzyme 2 (ACE2).
Zemlin AE; Wiese OJ
Ann Clin Biochem; 2020 Sep; 57(5):339-350. PubMed ID: 32369402
[TBL] [Abstract][Full Text] [Related]
18. Delineating clinical characteristics and comorbidities among 206 COVID-19 deceased patients in India: Emerging significance of renin angiotensin system derangement.
Majeed J; Ajmera P; Goyal RK
Diabetes Res Clin Pract; 2020 Sep; 167():108349. PubMed ID: 32712124
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 infections and COVID-19 mortalities strongly correlate with ACE1 I/D genotype.
Yamamoto N; Ariumi Y; Nishida N; Yamamoto R; Bauer G; Gojobori T; Shimotohno K; Mizokami M
Gene; 2020 Oct; 758():144944. PubMed ID: 32628976
[TBL] [Abstract][Full Text] [Related]
20. The Effect of Coronavirus Disease 2019 on Cardiovascular Diseases.
Askin L; Tanrıverdi O; Askin HS
Arq Bras Cardiol; 2020 Jun; 114(5):817-822. PubMed ID: 32491073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
